Subscribe free

HPB & Spleen ·

High Resection to Exploration Ratios and Variable Survival Outcomes in Pancreatic Ductal Adenocarcinoma Patients

Researchers conducted a study to investigate resection to exploration ratios (RER) and outcomes in patients with pancreatic ductal adenocarcinoma (PDAC). The overall RER was found to be 89.7%, with higher ratios observed in upfront explorations compared to post-neoadjuvant explorations. The primary reasons for uncompleted resection were occult metastases in presumed resectable/borderline resectable disease and local unresectability in locally advanced disease. Uncompleted resection was associated with a median survival of around one year, while post-pancreatectomy survival varied depending on the treatment setting, with a median of 36.9 months in the upfront setting and 29.5 months following neoadjuvant treatment.

Journal Article by Malleo G, Casciani F (…) Salvia R et 7 al. in Ann Surg

Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.

read the whole article in Ann Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

All papers in HPB & Spleen →